Clomoxir
Clomoxir (POCA) is a carnitine palmitoyltransferase I (CPT I) inhibitor with hypoglycemic activity. Clomoxir mediates the inhibition of CPT I via its active form POCA-CoA. Clomoxir inhibits long-chain fatty acid oxidation, ketogenesis, gluconeogenesis, de novo synthesis of cholesterol and fatty acids, and also mildly inhibits acetyl-CoA carboxylase. Clomoxir reduces blood glucose levels in various rodent and porcine models, alters plasma NEFA and cholesterol concentrations, induces hepatic lipid accumulation, peroxisome proliferation and mild myocardial hypertrophy in rats, and stimulates the pentose phosphate pathway in cultured human fibroblasts. Clomoxir can be used in diabetes-related research.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 88431-47-4
- 分子式: C14H17ClO3
- 分子量:268.74
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
|
CPT-1 |
Clomoxir (POCA) exerts multiple metabolic regulatory effects: its coenzyme A ester metabolite inhibits the activity of carnitine palmitoyltransferase in rat liver mitochondria; it suppresses de novo synthesis of cholesterol and fatty acids in the liver, and blocks lactate- and pyruvate-mediated gluconeogenesis stimulated by oleic acid; it activates the pentose phosphate pathway in human fibroblasts[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Clomoxir lowers plasma NEFA and cholesterol concentrations by approximately 50% in rats[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
化学情報
-
CAS 番号 88431-47-4
-
分子量 268.74
-
分子式 C14H17ClO3
-
SMILES
O=C(O)C1(OC1)CCCCCC2=CC=C(Cl)C=C2
-
別名
POCA
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)